QuantaLife

by | Jul 13, 2016 | Past Winners

QuantaLife QuantaLife provides advanced genetic analysis systems for research. QuantaLife has commercialized the Droplet Digital™ (ddPCR) system, the most accurate genetic analysis platform available today. The system is the first cost-effective, high-resolution...

Nodality

by | Jul 13, 2016 | Past Winners

Nodality Nodality’s Single Cell Network Profiling (SCNP) technology provides robust, human cell-based translational models of disease, drug activity and patient responses. SCNP reveals complex biology at the single-cell level, creating competitive advantages in...

Auxogyn

by | Jul 13, 2016 | Past Winners

Auxogyn Auxogyn is dedicated to advancing women’s reproductive health through diagnostic technologies that generate information to be used by physicians and their patients in making treatment decisions. We pursue a regulatory path to assure our technologies are safe...

Horizon

by | Jul 13, 2016 | Past Winners

Horizon Discovery Horizon Discovery Limited has developed a translational genomics platform and drug discovery toolbox that enables the development of new therapies targeted at the genetic features that drive an individual’s cancer. IPO, March 2014....

T2 Biosystems

by | Jul 13, 2016 | Past Winners

T2 Biosystems T2 Biosystems is an in vitro diagnostics company that has developed an innovative and proprietary technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. Their new class of clinical...